34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP)

Phase 2 ◽

Phase 2 Study ◽

Androgen Suppression

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer

Cancer ◽

10.1002/cncr.27416 ◽

2012 ◽

Vol 118 (19) ◽

pp. 4777-4784 ◽

Cited By ~ 38

Author(s):

Robert W. Ross ◽

Matthew D. Galsky ◽

Phil Febbo ◽

Marc Barry ◽

Jerome P. Richie ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase 2 ◽

Monitoring of Circulating Tumor Cells in Patients With High-Risk Nonmetastatic Prostate Cancer Treated With Radiation Therapy and Hormones: Preliminary Data of an Observational Prospective Phase 2 Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1272 ◽

2017 ◽

Vol 99 (2) ◽

pp. E280

Author(s):

A. Zapatero ◽

A. Gomez CaamaNo ◽

M. D. L. A. Cabeza Rodriguez ◽

L. Muinelo-Romay ◽

C. Martin de Vidales C ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Preliminary Data ◽

Phase 2 ◽

Phase 2 Study ◽

Prospective Phase

Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.10.005 ◽

2019 ◽

Vol 103 (2) ◽

pp. 344-352 ◽

Cited By ~ 2

Author(s):

Joan Carles ◽

Enrique Gallardo ◽

Montserrat Doménech ◽

Albert Font ◽

Joaquim Bellmunt ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Cancer Patients ◽

Randomized Study ◽

Androgen Deprivation ◽

Phase 2 ◽

Weekly Docetaxel

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer

Cancer ◽

10.1002/cncr.23910 ◽

2008 ◽

Vol 113 (11) ◽

pp. 3137-3145 ◽

Cited By ~ 10

Author(s):

William Kevin Kelly ◽

Susan Halabi ◽

Aymen Elfiky ◽

San-San Ou ◽

Jeff Bogart ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Androgen Deprivation ◽

Phase 2 ◽

Estramustine Phosphate ◽

Multicenter Phase ◽

Phase 2 Study: Feasibility and Acute Toxicity of Dose-Escalated Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Treatment of Pelvic Lymph Nodes in High-Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.957 ◽

2013 ◽

Vol 87 (2) ◽

pp. S364

Author(s):

S. Drodge ◽

A. Boychak ◽

S. Patel ◽

N. Usmani ◽

J. Amanie ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Intensity Modulated Radiation Therapy ◽

Phase 2 ◽

Concurrent Treatment ◽

Intensity Modulated ◽

High Risk Prostate Cancer ◽

Phase 2 Study ◽

Risk Prostate Cancer

Hypofractionated Intensity Modulated Radiation Therapy With Injection of Hyaluronic Acid for Localized Prostate Cancer: Results of a Phase 2 study (RPAH1)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.447 ◽

2013 ◽

Vol 87 (2) ◽

pp. S173

Author(s):

O. Chapet ◽

E. Decullier ◽

A. Faix ◽

A. Ruffion ◽

P. Jalade ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Hyaluronic Acid ◽

Intensity Modulated Radiation Therapy ◽

Phase 2 ◽

Intensity Modulated ◽

Faculty Opinions recommendation of 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.723495454.793514257 ◽

2016 ◽

Author(s):

Badrinath Konety

Keyword(s):

Prostate Cancer ◽

Randomized Controlled Trial ◽

Radiation Therapy ◽

Controlled Trial ◽

Randomized Controlled ◽

Androgen Suppression

Are Daily Orthogonal kVkV Images Sufficient for Image Guided Radiation Therapy of Prostate Cancer Patients Post-Radical Prostatectomy? Final Analysis of a Pilot Phase 2 Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.969 ◽

2013 ◽

Vol 87 (2) ◽

pp. S369

Author(s):

T.M. Niazi ◽

J. Papayanatos ◽

N. Tomic ◽

B. Bahoric ◽

F. Bladou ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Radical Prostatectomy ◽

Cancer Patients ◽

Final Analysis ◽

Phase 2 ◽

Pilot Phase ◽

Image Guided Radiation Therapy ◽

Image Guided ◽

The Prognostic Value of Expression of HIF1α, PAK-6, and PSMB4 in Intermediate- and High-Risk Localized Prostate Cancer Patients Treated With Androgen Deprivation and Dose Escalation Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.1755 ◽

2013 ◽

Vol 87 (2) ◽

pp. S662-S663

Author(s):

A. Zapatero ◽

M. Morente ◽

C. Martin de Vidales ◽

C. Lopez ◽

M. Adrados ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Cancer Patients ◽

Dose Escalation ◽

Prognostic Value ◽

Androgen Deprivation ◽

Localized Prostate Cancer

Phase II study of combined external beam radiation therapy (EBRT), brachytherapy (PB), total androgen suppression (TAS), and adjuvant docetaxel (AD) in poor-risk, localized prostate cancer (PCa)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4764 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4764-4764

Author(s):

S. J. Dibiase ◽

N. Dawson ◽

M. Naslund ◽

A. Hussain ◽

R. Kataria ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

External Beam Radiation Therapy ◽

External Beam Radiation ◽

External Beam ◽

Beam Radiation ◽

Androgen Suppression